Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
J Family Med Prim Care ; 11(11): 6795-6800, 2022 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-36993119

RESUMEN

Introduction: Children at schools are at risk of getting injuries during their activities. In the absence of medical support and delays in ambulance arrival, teachers are the first responders to provide first aid when accidents occur. There is a lack of information about schoolteachers' awareness and knowledge about first aid administration. This study aimed to assess the current level of knowledge and attitude toward paediatric first aid among elementary schoolteachers in Jeddah of Saudi Arabia. Methodology: This is a cross-sectional study. An online questionnaire-based survey was administered to teachers in primary male schools in the Jeddah region. Statistical analysis was performed using JMP software, continuous variables were presented as mean and standard deviation (SD), data for categorical variables were presented as frequencies and percentages and statistical tests ANOVA and Chi Square were also used. The P values <0.05 were considered statistically significant. Results: A total of 221 male schoolteachers were interviewed online in our study. Most of the research participants were aged between 26 and 50 years and most had a bachelor's degree as the highest education (81.9%). In addition, half of the participants, that is, 50.2%, had between 20 years and 30 years of experience in teaching. Almost all the teachers (99.5%) heard about first aid with more than half (57%) attending training in first aid. The source of information for almost half of them (48%) came from social media and most of them (85%) agree that there is a need for first aid education. Conclusion: Our findings reveal that schoolteachers know about the importance of first aid but lack the training and skills to administer first aid before the ambulance arrives. Therefore, there is an urgent need for proper first aid training for teachers and support staff to prepare them to deal with all the emergencies that most frequently arise at children's schools.

2.
Age Ageing ; 50(4): 1129-1136, 2021 06 28.
Artículo en Inglés | MEDLINE | ID: mdl-33993209

RESUMEN

BACKGROUND: Patients with lower limb fractures who are non-weight bearing are at risk of the complications of the associated immobility and disability, particularly people with frailty, but there is lack of clarity about what constitutes optimal care for such patients. A scoping literature review was conducted to explore what evidence is available for the management of this patient group. METHODS: MEDLINE (PubMed) CINAHL, EMBASE and the Cochrane databases of published literature and the HMIC and SIGLE sites for grey literature were searched for primary research studies and expert reports, using an iterative approach initially including the key term 'non-weight bearing'. All study types were included. Analysis was by narrative synthesis. RESULTS: No papers were identified from a search using the key phrase 'non-weight bearing'. With this term removed, 11 indirectly relevant articles on lower limb fractures were retrieved from the searches of the electronic databases comprising three observational studies, five non-systematic review articles, a systematic review, an opinion piece and a survey of expert opinion that had relevance to restricted weight bearing patients. The observational studies indicated depression, cognition and nutrition affect outcome and hence have indirect relevance to management. The non-systematic reviews articles emphasised the importance of maintaining strength and range of movement during immobilisation and advised an orthogeriatric model of care. Fourteen UK and 97 non-UK guidelines relevant to fragility fractures, falls and osteoporosis management were found in the grey literature, but none made specific recommendations regarding the management of any period of non-weight bearing. DISCUSSION: These findings provide a summary of the evidence base that can be used in the development of a clinical guideline for these patients but is not sufficient. We propose that, a guideline should be developed for these patients using an expert consensus process.


Asunto(s)
Fracturas Óseas , Fragilidad , Anciano , Consenso , Fracturas Óseas/diagnóstico , Fracturas Óseas/terapia , Fragilidad/diagnóstico , Fragilidad/terapia , Humanos , Extremidad Inferior , Estado Nutricional
3.
Cancer Biol Ther ; 18(4): 214-221, 2017 04 03.
Artículo en Inglés | MEDLINE | ID: mdl-28278078

RESUMEN

BCR-ABL kinase domain (KD) mutations are well known for causing resistance against tyrosine kinase inhibitors (TKIs) and disease progression in chronic myeloid leukemia (CML). In recent years, compound BCR-ABL mutations have emerged as a new threat to CML patients by causing higher degrees of resistance involving multiple TKIs, including ponatinib. However, there are limited reports about association of compound BCR-ABL mutations with disease progression in imatinib (IM) sensitive CML patients. Therefore, we investigated presence of ABL-KD mutations in chronic phase (n = 41), late chronic phase (n = 33) and accelerated phase (n = 16) imatinib responders. Direct sequencing analysis was used for this purpose. Eleven patients (12.22%) in late-CP CML were detected having total 24 types of point mutations, out of which 8 (72.72%) harbored compound mutated sites. SH2 contact site mutations were dominant in our study cohort, with E355G (3.33%) being the most prevalent. Five patients (45%) all having compound mutated sites, progressed to advanced phases of disease during follow up studies. Two novel silent mutations G208G and E292E/E were detected in combination with other mutants, indicating limited tolerance for BCR-ABL1 kinase domain for missense mutations. However, no patient in early CP of disease manifested mutated ABL-KD. Occurrence of mutations was found associated with elevated platelet count (p = 0.037) and patients of male sex (p = 0.049). The median overall survival and event free survival of CML patients (n = 90) was 6.98 and 5.8 y respectively. The compound missense mutations in BCR-ABL kinase domain responsible to elicit disease progression, drug resistance or disease relapse in CML, can be present in yet Imatinib sensitive patients. Disease progression observed here, emphasizes the need of ABL-KD mutation screening in late chronic phase CML patients for improved clinical management of disease.


Asunto(s)
Antineoplásicos/farmacología , Resistencia a Antineoplásicos/genética , Proteínas de Fusión bcr-abl/genética , Leucemia Mielógena Crónica BCR-ABL Positiva/genética , Recurrencia Local de Neoplasia/genética , Inhibidores de Proteínas Quinasas/farmacología , Adolescente , Adulto , Antineoplásicos/uso terapéutico , Niño , Análisis Mutacional de ADN , Progresión de la Enfermedad , Supervivencia sin Enfermedad , Femenino , Estudios de Seguimiento , Humanos , Mesilato de Imatinib/uso terapéutico , Estimación de Kaplan-Meier , Leucemia Mielógena Crónica BCR-ABL Positiva/sangre , Leucemia Mielógena Crónica BCR-ABL Positiva/tratamiento farmacológico , Leucemia Mielógena Crónica BCR-ABL Positiva/mortalidad , Masculino , Persona de Mediana Edad , Mutación Missense , Recurrencia Local de Neoplasia/sangre , Recurrencia Local de Neoplasia/tratamiento farmacológico , Recurrencia Local de Neoplasia/mortalidad , Recuento de Plaquetas , Mutación Puntual , Inhibidores de Proteínas Quinasas/uso terapéutico , Adulto Joven
4.
Asian Pac J Cancer Prev ; 16(17): 7523-7, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26625756

RESUMEN

BACKGROUND: Pediatric acute lymphoblastic leukemia (pALL) patients at King Abdulaziz Medical City represent a pure Saudi Arabian population. ETV6-RUNX1 positive pALL patients have good prognosis as compared to ETV6-RUNX1 negative counterparts. Therefore, frequencies of these two patient groups have a huge consideration in treatment strategies of pALL in a given population. Different geographical locations have been reported to have different frequencies of ETV6-RUNX1 ranging from 10% in Southeast Asia to 30% in Australia. AIM: Therefore, the objective of this study was to establish the ETV6-RUNX1 status of Saudi Arabian pALL patients and its association with clinical parameters and early remission. MATERIALS AND METHODS: Clinical parameters and ETV6-RUNX1 status (using FISH technique) of pALL patients attending the Pediatric Oncology Clinic, King Abdulaziz Medical City, Riyadh from 2006 to 2011 were studied. Comparisons between ETV6-RUNX1 positive and negative groups were accomplished using chi-square test or Fisher's exact test. All statistical analyses were performed using SAS version 9.2 (SAS Institute, Inc., Cary, NC). RESULTS: Out of 54 patients, 33 were male and 21 were females (ratio 1.57:1). B- and T-cell lineages were found in 47 (87%) and 7 (13%) patients respectively. Only 5 (9.3%) patients were ETV6-RUNX1 positive while 49(80.7%) were ETV6-RUNX1 negative. All ETV6-RUNX1 patients (100%) were of B-cell lineage and 80% (4/5) were in the 3-7 year age group. None of the ETV6-RUNX11 patients had ≥ 5% blasts (no remission) at day 14 as compared with 9% in the ETV6-RUNX1 negative group (Figure 1). CONCLUSIONS: Frequency of ETV6-RUNX1 positive patients (less than 10%) in our pALL patients is much lower than reported for most European countries, North America, Australia and Japan while it is in accordance with ETV6-RUNX1 frequencies from Egypt (11.6%), Pakistan (10%), Spain (2%) and India (5-7%). This shows ethnic differences in genetics of pALL as well as higher frequencies of ETV6-RUNX1 positive pALL mostly in more industrialized countries, probably due to some industrial pollutants or westernized lifestyle.


Asunto(s)
Subunidad alfa 2 del Factor de Unión al Sitio Principal/genética , Frecuencia de los Genes/genética , Proteínas de Fusión Oncogénica/genética , Leucemia-Linfoma Linfoblástico de Células Precursoras B/genética , Leucemia-Linfoma Linfoblástico de Células T Precursoras/genética , Adolescente , Linfocitos B/patología , Linaje de la Célula/inmunología , Niño , Preescolar , Femenino , Geografía , Humanos , Hibridación Fluorescente in Situ , Masculino , Pronóstico , Arabia Saudita , Linfocitos T/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...